Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Procalcitonin for the prognosis of adverse events

Procalcitonin for the prognosis of adverse events

US Patent 11835531 · Granted Dec 5, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Procalcitonin for the diagnosis of bacterial infections and guidance of antibiot2022
Use of procalcitonin (PCT) in risk stratification and prognosis of patients with2022
Method of obtaining a binder to prepro-vasopressin or fragments thereof2021
Diagnosis and risk stratification of infections and chronic diseases of the resp2020
Use of procalcitonin (PCT) in risk stratification and prognosis of patients with2019
In vitro method for early or differential diagnosis or prognosis of myocardial i2019
Immunoassay for the detection of procalcitonin2018
Augurin immunoassay2018
Arginine vasopressin pro-hormone as predictive biomarker for diabetes2018
Determination of a midregional proadrenomedullin partial peptide in biological f2018
Methods of treatment using ADM antibodies2017
Risk assessment for antibiotics treatment in patients suffering from primary non2017